Literature DB >> 19546878

NK cells enhance the induction of CTL responses by IL-15 monocyte-derived dendritic cells.

Melinda Y Hardy1, Andrew J Kassianos, Annelie Vulink, Ray Wilkinson, Sarah L Jongbloed, Derek N J Hart, Kristen J Radford.   

Abstract

Dendritic cells differentiated from monocytes (MoDC) in the presence of GM-CSF and IL-15 (IL-15 MoDC) exhibit superior migration and cytotoxic T-lymphocyte (CTL) induction compared with MoDC differentiated in IL-4 and GM-CSF (IL-4 MoDC) and are promising candidates for DC immunotherapy. We explored the mechanisms by which IL-15 MoDC induce CTL. IL-15 MoDC expressed higher levels of CD40 and secreted high levels of TNF-alpha, but little or no IL-12p70 compared with IL-4 MoDC. Despite immuno-selecting monocytes to >97% purity before MoDC generation, a tiny population (0.2%) of natural killer (NK) cells was identified that was increased sevenfold during IL-15 MoDC, but not IL-4 MoDC differentiation. These NK cells produced high levels of IFN-gamma and were responsible for the enhanced CTL-inducing capacity of the IL-15 MoDC, but not for their increased expression of CD40 or secretion of TNF-alpha. Interestingly, a proportion of IL-15 MoDC were found to express the NK cell marker, CD56, but these did not secrete IFN-gamma. These data implicate a role for small percentages of NK cells in the enhanced capacity of IL-15 MoDC to induce tumour-specific CTL independent of IL-12p70.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546878     DOI: 10.1038/icb.2009.44

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  12 in total

1.  Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection.

Authors:  Yuan Liu; Jian Zheng; Yinping Liu; Liyan Wen; Lei Huang; Zheng Xiang; Kwok-Tai Lam; Aizhen Lv; Huawei Mao; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2017-04-17       Impact factor: 11.530

Review 2.  NK cells: key to success of DC-based cancer vaccines?

Authors:  Eva Lion; Evelien L J M Smits; Zwi N Berneman; Viggo F I Van Tendeloo
Journal:  Oncologist       Date:  2012-08-20

3.  ErbB2 promotes endothelial phenotype of human left ventricular epicardial highly proliferative cells (eHiPC).

Authors:  Sergey Ryzhov; Michael P Robich; Daniel J Roberts; Amanda J Favreau-Lessard; Sarah M Peterson; Edward Jachimowicz; Rutwik Rath; Calvin P H Vary; Reed Quinn; Robert S Kramer; Douglas B Sawyer
Journal:  J Mol Cell Cardiol       Date:  2017-12-29       Impact factor: 5.000

Review 4.  Functions of IL-15 in anti-viral immunity: multiplicity and variety.

Authors:  Katherine C Verbist; Kimberly D Klonowski
Journal:  Cytokine       Date:  2012-06-15       Impact factor: 3.861

5.  Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.

Authors:  Sébastien Anguille; Evelien L J M Smits; Nathalie Cools; Herman Goossens; Zwi N Berneman; Vigor F I Van Tendeloo
Journal:  J Transl Med       Date:  2009-12-18       Impact factor: 5.531

Review 6.  Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.

Authors:  Sébastien Anguille; Eva Lion; Johan Van den Bergh; Heleen H Van Acker; Yannick Willemen; Evelien L Smits; Viggo F Van Tendeloo; Zwi N Berneman
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

7.  Transcriptional IL-15-directed in vivo DC targeting DNA vaccine.

Authors:  S Tian; Z Liu; C Donahue; H S Noh; L D Falo; Z You
Journal:  Gene Ther       Date:  2009-09-03       Impact factor: 5.250

8.  Protective role of ErbB3 signaling in myeloid cells during adaptation to cardiac pressure overload.

Authors:  Haifeng Yin; Amanda J Favreau-Lessard; Joanne T deKay; Yodit R Herrmann; Michael P Robich; Robert A Koza; Igor Prudovsky; Douglas B Sawyer; Sergey Ryzhov
Journal:  J Mol Cell Cardiol       Date:  2020-11-28       Impact factor: 5.000

9.  Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells.

Authors:  Shuhong Han; Yichen Wang; Bei Wang; Ekta Patel; Starlyn Okada; Li-Jun Yang; Jan S Moreb; Lung-Ji Chang
Journal:  J Immune Based Ther Vaccines       Date:  2010-11-24

10.  STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells.

Authors:  Starlyn Okada; Shuhong Han; Ekta S Patel; Li-Jun Yang; Lung-Ji Chang
Journal:  Immunol Cell Biol       Date:  2015-01-13       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.